Cardiovascular disease in women

Mount Sinai Journal of Medicine

Volumn 70, Issue 5, 2003, Pages 293-305

  Duvall, William Lane ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery disease; Coronary heart disease; Epidemiology; Hormone replacement therapy; Prevention; Risk factors; Women

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; ESTROGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; GESTAGEN; GLYCERYL TRINITRATE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MEDROXYPROGESTERONE; ORAL CONTRACEPTIVE AGENT; PLACEBO; PROGESTERONE; RALOXIFENE;

AGE; BREAST CANCER; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CIGARETTE SMOKING; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE CLASSIFICATION; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DYSLIPIDEMIA; ENDOMETRIUM HYPERPLASIA; EXERCISE TEST; FEMALE; FIBRINOLYTIC THERAPY; HEALTH CARE UTILIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MENOPAUSE; MORTALITY; OBESITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL ACTIVITY; PREVALENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; STRESS ECHOCARDIOGRAPHY; THROMBOEMBOLISM; UNITED STATES;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIFE STYLE; MYOCARDIAL REVASCULARIZATION; WOMEN'S HEALTH;

EID: 0242539873     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. National Health and Nutrition Examination Survey III (NHANES III), 1988-94, CDC/NCHS and the American Heart Association.
2. American Heart Association. 2002 Heart and stroke statistical update. Dallas, Texas: American Heart Association, 2001
3. Brister SJ, Turek MA. Introduction to women and ischemic heart disease. Can J Cardiol 2001; 17(Suppl D):5D-6D.
4. Harris DJ, Douglas PS. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med 2000; 343:475-480.
5. Lerner DJ, Kannel WB. Patterns of coronary heart disease mortality and morbidity in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111:383-390.
6. Schildkraut JM, Meyers RH, Cupples LA, et al. Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am J Cardiol 1989; 64:555-559.
7. Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316:1105-1110.
8. Willett WC, Green A, Stampfer MJ, et al. Relative and absolute risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317:1303-1309.
9. Bartecchi C, Mackenzie T, Schrier R. The human costs of tobacco use. N Engl J Med 1994; 330:907-912.
10. Hansen EF, Andresen LT, von Eyben FE. Cigarette smoking and age at first myocardial infarction and influence of gender and extent of smoking. Am J Cardiol 1993; 171:1439-1442.
11. Stradel B. Oral contraceptives and cardiovascular disease. N Engl J Med 1981; 305:672-677.
12. Thorgood M, Mann J, Murphy M, Vessey M. Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case control study. Br J Obstet Gynecol 1991; 98:1245-1253.
13. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991; 265:627-631.
14. Kannel WB, McGee DL. Diabetes and glucose intolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 1979; 2:120-126.
15. Manson JE, Rimm EB, Stampfer MJ, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151:1141-1147.
16. Abbott RD, Donahue RP, Kannel WB, Wilson P. The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study. JAMA 1988; 260; 3456-3460.
17. Savage MP, Krolewski AS, Kenien GG, et al. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol 1988; 62:665-669.
18. Chun BY, Dobson AJ, Heller RF. The impact of diabetes on survival among people with first myocardial infarction. Diabetes Care 1997; 20:704-708.
19. Castelli WP, Garrison RJ, Wilson P, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986; 256:2835-2838.
20. Manolio TA, Pearson TA, Wenger NK, et al. Cholesterol and heart disease in older persons and women: review of an NHLBI workshop. Ann Epidemiol 1992; 2:161-176.
21. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States: the National Health and Nutrition Examination Survey: I - Epidemiologic follow-up study. Arch Intern Med 1989; 149:780-788.
22. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Int Med 1997; 157:2413-2446.
23. Stokes J, Kannel WB, Wolf PA, et al. Blood pressure as a risk factor for cardiovascular disease: the Framingham Study - 30 years of follow-up. Hypertension 1989; 13(Suppl I):I13-I18.
24. Kushi LH, Fee RH, Folsom AR, et al. Physical activity and mortality in post-menopausal women. JAMA 1997; 277:1287-1292.
25. Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 2000; 343:530-537.
26. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67:968-977.
27. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322:882-889.
28. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995; 333:677-685.
29. Zucker DR, Griffith JL, Beshansky JR, Selker HP. Presentation of acute myocardial infarction in men and women. J Gen Intern Med 1997; 12:79-87.
30. Sullivan AK, Holdright DR, Wright CA, et al. Chest pain in women: clinical, investigative, and prognostic features. BMJ 1994; 308:883-886.
31. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham study. N Eng J Med 1984; 311:1144-1147.
32. Kwok Y, Kim C, Grady D, et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999; 83:660-666.
33. Gianrossi R, Detrano R, Mulvihill D, et al. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 1989; 80:87-98.
34. Isaac D, Walling A. Clinical evaluation of women with ischemic heart disease: diagnosis and noninvasive testing. Can J Cardiol 2001; 17 Suppl D:38D-48D.
35. Alexander KP, Shaw LJ, Shaw LK, et al. Value of exercise treadmill testing in women. J Am Coll Cardiol 1998; 32:1657-1664.
36. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Eng J Med 1996; 334:1311-1315.
37. Gibbons RJ, Balady GJ, Beasley JW et al. ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997; 30:260-311.
38. Taillefer R, DePuey EG, Udelson JE, et al. Comparative diagnostic accuracy of TI-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997; 29:69-77.
39. Marwick TH, Shaw LJ, Lauer MS, et al. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. Am J Med 1999; 106(2):172-178.
40. Travin MI, Duca MD, Kline GM, et al. Relation of gender to physician use of test results and to the prognostic value of stress technetium 99m sestamibi myocardial single-photon emission computed tomography scintigraphy. Am Heart J 1997; 134:73-82.
41. Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998; 280:913-920.
42. Tong AT, Douglas PS. Stress echocardiography in women. Cardiol Clin 1999; 17:573-582.
43. McCully RB, Roger VL, Mahoney DW, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol 1998; 31:144-149.
44. Heupler S, Mehta R, Lobo A, et al. Prognostic implications of exercise echocardiography in women with known or suspected coronary artery disease. J Am Coll Cardiol 1997; 30:414-420.
45. Cortigiani L, Dodi C, Paolini EA, et al. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease. J Am Coll Cardiol 1998; 32:1975-1981.
46. Chuah SC, Pellikka PA, Roger VL, et al. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 1998; 97:1474-1480.
47. O'Keefe JH, Barnhart CS, Bateman TM. Comparison of stress echocardiography and stress myocardial perfusion scintigraphy for diagnosing coronary artery disease and assessing its severity. Am J Cardiol 1995; 75:25D-34D.
48. Marrugat J, Sala J, Masia R, et al. Mortality differences between men and women following first myocardial infarction. RESCATE Investigators. JAMA 1998; 280:1405-1409.
49. Weaver WD, White HD, Wilcox RG, et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. Gusto-1 Investigators. JAMA 1996; 275:777-782.
50. Malacrida R, Genoni M, Maggioni AP, et al. A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. N Eng J Med 1998; 338:8-14.
51. Gan SC, Beaver SK, Houck PM, et al. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Eng J Med 2000; 343:8-15.
52. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men. Circulation 1991; 83:484-491.
53. Clarke KW, Gray D, Keating NA, Hampton JR, Do women with acute myocardial infarction receive the same treatment as men? BMJ 1994; 309:563-566.
54. Kudenchuk PJ, Maynard C, Martin JS, et al. Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (The Myocardial Infarction Triage and Intervention Registry). Am J Cardiol 1996; 78:9-14.
55. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Eng J Med 1999; 341:226-232.
56. Scirica BM, Moliterno DJ, Every NR, et al. Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). Am J Cardiol 1999; 84:1145-1150.
57. Maynard C, Litwin PE, Martin JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med 1992; 152(5): 972-976.
58. Schwartz LM, Fisher ES, Tosteson NA, et al. Treatment and health outcomes of women and men in a cohort with coronary artery disease. Arch Intern Med 1997; 157:1545-1551.
59. Tobin JN, Wassertheil-Smoller S, Wexler JP, et al. Sex bias in considering coronary bypass surgery. Ann Intern Med 1987; 107:19-25.
60. Steingart R, Packer M, Hamm P, et al. Sex differences in the management of coronary artery disease: Survival and Ventricular Enlargement investigators. N Eng J Med 1991; 325:226-230.
61. Stone PH, Thompson B, Anderson H, et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction in the United States and Canada (the TIMI III Registry). JAMA 1996; 275:1104-1112.
62. Chandra NC, Ziegelstein RC, Rogers WJ, et al. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med 1998; 158:981-988.
63. Kelsey S, James M, Holubkov AL, et al. Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute Coronary Angioplasty Registry. Circulation 1993; 87:720-727.
64. Ellis SG, Myler RK, King SB, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988; 77:372-379.
65. Bell MR, Holmes DR, Berger PB, et al. The changing in-hospital mortality of women undergoing percutaneous transluminal angioplasty. JAMA 1993; 269:2091-2095.
66. Arnold AM, Mick MJ, Piedmonte MR, Simpfendorfer C. Gender differences for coronary angioplasty. Am J Cardiol 1994; 74:18-21.
67. Kells CM, Mickleborough L. Revascularization strategies in women with ischemic heart disease. Can J Cardiol 2001; 17(Suppl D):53D-56D.
68. Jacobs AK, Kelsey SF, Brooks MM, et al. Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI). Circulation 1998; 98:1279-1285.
69. Hall RJ, Elayda MA, Gray A, et al. Coronary artery bypass: long-term follow-up of 22,284 consecutive patients. Circulation 1983; 68(Suppl II):II20-II26.
70. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Eng J Med 1991; 325:221-225.
71. Mickleborough LL, Takagi Y, Maruyama H, et al. Is sex a factor in determining operative risk for aortocoronary bypass graft surgery? Circulation 1995; 92(Suppl II):II80-II84.
72. Edwards FH, Grover FL, Shroyer AL, et al. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg 1997; 63:903-908.
73. Brandrup-Wognsen G, Berggren H, Hartford M, et al. Female sex is associated with increased mortality and morbidity early, but not late, after coronary artery bypass grafting. Eur Heart J 1996; 17:1426-1431.
74. Stewart RD, Blair JL, Emond CE, et al. Gender and functional outcome after coronary artery bypass. Surgery 1999; 126:184-190.
75. Davis KD, Chaitman B, Ryan T, et al. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. J Am Coll Cardiol 1995; 25:1000-1009.
76. Sites CK. Hormone replacement therapy: cardiovascular benefits for aging women. Coron Artery Dis 1998; 9:789-793.
77. Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325:1196-1204.
78. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 1995 Jan 18;273(3):199-208.
79. Walsh BW, Kuller LH, Wild RA, et al. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 1998; 279:1445-1451.
80. Perregaux D, Chaudhuri A, Mohanty P, et al. Effect of gender differences and estrogen replacement therapy on vascular reactivity. Metabolism 1999; 48:227-232.
81. Best PJ, Berger PB, Miller VM, Lerman A. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 1998; 128:285-288.
82. McGrath BP, Liang YL, Teede H, et al. Age-related deterioration in arterial structure and function in postmenopausal women: impact of hormone replacement therapy. Arterioscler Thromb Vasc Biol 1998; 18:1149-1156.
83. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20:47-63.
84. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Int Med 1992; 117:1016-1037.
85. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991; 151:75-78.
86. O'Brien JE, Peterson ED, Keeler GP, et al. Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions. J Am Coll Cardiol 1996; 28:1111-1118.
87. Sullivan JM, El-Zeky F, Vander Zwaag R, Ramanathan KB. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am J Cardiol 1997; 79:847-850.
88. O'Keefe JH, Kim SC, Hall RR, et al. Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol 1997; 29:1-5.
89. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991; 115:455-456.
90. Petitti DB. Coronary heart disease and estrogen replacement therapy: can compliance bias explain the results of observational studies? Ann Epidemiol 1994; 4:115-118.
91. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997; 336:1769-1775.
92. Stampfer MJ, Willett WC, Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Eng J Med 1985; 313:1044-1049.
93. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Eng J Med 1991; 325:756-762.
94. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Eng J Med 1996; 335:453-461.
95. Grodstein F, Manson JE, Colditz GA, et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000; 133:933-941.
96. Grodstein F, Manson JE, Stampfer MJ. Postmenopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study. Ann Intern Med 2001; 135:1-8.
97. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in women. JAMA 1998; 280:605-613.
98. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002; 288:49-57.
99. Hulley S, Furberg C, Barrett-Connor E, et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002; 288:58-66.
100. Mosca L, Collins P, Herrington D, et al. Hormone replacement therapy and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation 2001; 104:499-503.
101. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.
102. Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Eng J Med 2000; 343:522-529.
103. Barrett-Connor E, Grady D, Sashegyi A, et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women. Four year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 2002; 287:847-857.